by Tomonori Nagano | Tue, July 13, 2021 Japanese homegrown COVID-19 vaccine will become available in early 2022 5 1 vote Article Rating Daiichi Sankyo’s COVID-19 vaccine is in the Phase 3 trials and will become available in March 2022 if everything goes well. https://asia.nikkei.com/Spotlight/Coronavirus/Japan-nears-homegrown-vaccine-with-Daiichi-Sankyo-Phase-3-trials Share this:TweetShare on TumblrEmailReddit Related